Human antibodies reactive to NeuGcGM3 ganglioside have cytotoxic antitumor properties (Q39210534)

10 September 2017

title

Human antibodies reactive to NeuGcGM3 ganglioside have cytotoxic antitumor properties (English)

1 reference

10 September 2017

0 references

1 reference

Nely Rodríguez-Zhurbenko

1 reference

10 September 2017

Darel Martínez

1 reference

10 September 2017

Rancés Blanco

1 reference

10 September 2017

Teresa Rondón

1 reference

10 September 2017

Tania Griñán

1 reference

10 September 2017

Ana María Hernández

1 reference

10 September 2017

language of work or name

English

0 references

publication date

8 February 2013

1 reference

European Journal of Immunology

10 September 2017

published in

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

page(s)

826-837

1 reference

Structures, biosynthesis, and functions of gangliosides--an overview

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

The molecular basis for the absence of N-glycolylneuraminic acid in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

CMP-N-Acetylneuraminic acid hydroxylase is exclusively inactive in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Sequencing the chimpanzee genome: insights into human evolution and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

N-Glycolylneuraminic acid in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

An anti-idiotype vaccine elicits a specific response to N-glycolyl sialic acid residues of glycoconjugates in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Characterization of the antibody response against NeuGcGM3 ganglioside elicited in non-small cell lung cancer patients immunized with an anti-idiotype antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Anti-NeuGcGM3 Antibodies, Actively Elicited by Idiotypic Vaccination in Nonsmall Cell Lung Cancer Patients, Induce Tumor Cell Death by an Oncosis-Like Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Augmentation of natural antiganglioside IgM antibodies in lower motor neuron disease (LMND) and role of CD5+ B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Anti-ganglioside antibody-induced tumor cell death by loss of membrane integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Caspase family proteases and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Natural IgM antibodies against oxidation-specific epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Natural antibodies in health and disease: an overview of the first international workshop on natural antibodies in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Glycoimmunomics of human cancer: current concepts and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Treatment of neuroblastoma with human natural antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Natural antibodies and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Peripheral T cells select the B-cell repertoire in old mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Immunological studies of aging. IV. The contribution of thymic involution to the immune deficiencies of aging mice and reversal with thymopoietin32-36

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70−

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

The double life of a B-1 cell: self-reactivity selects for protective effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Glycosphingolipids: structure, biological source, and properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Switching on cytotoxicity by a single mutation at the heavy chain variable region of an anti-ganglioside antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Human antiganglioside autoantibodies: validation of ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Kidney sulfatides in mouse models of inherited glycosphingolipid disorders: determination by nano-electrospray ionization tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

The nomenclature of cell death: recommendations of an ad hoc Committee of the Society of Toxicologic Pathologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Gangliosides as immunomodulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

7 January 2021

Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer: report of a phase I trial

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

7 January 2021

Cytotoxic natural antibodies against human tumours: an option for anti-cancer immunotherapy?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

7 January 2021

A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242693

7 January 2021

Identifiers

DOI

10.1002/EJI.201242693

1 reference

10 September 2017

1 reference